Dr. Kieran Sahasrabudhe is a faculty member in the Division of Hematology, Medical Oncology, and Palliative Care in the Department of Medicine. He is an active member of the American Medical Association, the American Society of Hematology, The American Society of Clinical Oncology and The American Association for Cancer Research. He has served as an ad hoc reviewer for the Journal of the National Comprehensive Cancer Network. Past honors include receiving the Excellence in Hematology and Oncology Research award from the Hematology and Medical Oncology Fellowship at The Ohio State University, as well as being selected to participate in the Methods in Clinical Cancer Research Workshop hosted by the American Association of Cancer Research and the American Society of Clinical Oncology. He has an interest in quality improvement and previously served as co-director of the Acute Leukemia Quality Program at Ohio State.
Dr. Sahasrabudhe's clinical interests include general hematology with a specific focus on acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPNs).
Dr. Sahasrabudhe's research interests focus on improving treatments for patients with acute leukemias and myeloid diseases. He is involved in clinical trials studying investigational therapies as well as outcomes research. His research has been presented at local and national meetings and has been published in journals such as Blood, Lancet Haematology, and the Journal of Leukemia and Lymphoma.